Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
about
Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011)Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsisEffectiveness and safety of procalcitonin evaluation for reducing mortality in adult patients with sepsis, severe sepsis and septic shockDeveloping a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)HDL in sepsis - risk factor and therapeutic approachAcute CholecystitisBiomarkers for Sepsis: What Is and What Might Be?Update of Sepsis: Recent Evidences about Early Goal Directed TherapyLysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic DataCurrent challenges in understanding immune cell functions during septic syndromesPregnancy-Associated Severe Sepsis: Contemporary State and Future ChallengesHost innate immune responses to sepsisEvaluation of vitamin C for adjuvant sepsis therapyA Neutrophil Phenotype Model for Extracorporeal Treatment of SepsisNecrotizing Fasciitis Associated with Pregnancy: a Population-Based Cohort StudyContemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort studyAntipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis.Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.Identifying Patients With Sepsis on the Hospital Wards.Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data.Sepsis in Canadian children: a national analysis using administrative data.Objective Sepsis Surveillance Using Electronic Clinical Data.Sepsis surveillance from administrative data in the absence of a perfect verification.Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Risk stratification and prognostic performance of the predisposition, infection, response, and organ dysfunction (PIRO) scoring system in septic patients in the emergency department: a cohort study.Comparison of outcomes from sepsis between patients with and without pre-existing left ventricular dysfunction: a case-control analysisMyeloid-derived suppressor cells in sepsisA point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsisMortality predictors in renal transplant recipients with severe sepsis and septic shock.Sepsis-related deaths in Brazil: an analysis of the national mortality registry from 2002 to 2010Hospital readmission and healthcare utilization following sepsis in community settings.Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?The Nociceptin/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass.Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.Functional outcomes of general medical patients with severe sepsis.Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis.Current knowledge and future directions of TLR and NOD signaling in sepsis
P2860
Q21999482-35750967-86F3-4DA5-8611-587C3A4345B9Q24193361-DC4CFC36-F537-423A-8C51-B9C864A94699Q24200832-8F066F73-D716-4868-B6B5-673BC1F0E3BBQ26768292-629E0222-DD45-492C-8013-B1B1E63AA20AQ26777964-50575A17-1612-46A1-B32B-8BBF2AA6B797Q26782884-8A353FFA-B24A-4472-AA3A-9A4774E49C84Q26785255-6D7C7DFE-3B54-4CC1-8F08-69EAF503D4A4Q26801608-6672DD07-5278-44FB-AF53-02BFADC24203Q26823225-DFBFF9EF-3753-4F65-A26C-E15AE9DECD3FQ26849252-53735A36-B3CB-4384-BDBE-FE8E9221E61AQ26864623-B734A7EF-11D6-496D-AFD4-63F00833D0CBQ26864635-E948064D-8780-4C75-8C0E-F117F001E019Q27026804-30BB3E29-F1E8-4673-8930-B335EEA7A33FQ27318669-A205A805-8156-45CE-987D-F85C7CC89177Q28384387-B610142D-9244-4146-A4B6-D4C4C2D87C3FQ28391653-2870F0ED-8DEE-44CF-9DA0-2830473C44EBQ30235830-73E186F7-32B4-48E7-86DA-2EED1AD88348Q30238953-92738626-E817-4BC1-B377-90F2CFB746E0Q30249170-2E7AFAB6-43EF-416C-ADEB-A02B25F9C5F1Q30855320-42BDF9EB-59C6-4999-B895-72D6C277750EQ30881137-61E77324-CD6F-4E27-A72D-55E2594ECBD9Q31015229-E31645B7-CFC6-44C3-893E-B447997E5A75Q31127051-93673D6A-9F33-4380-9B5B-906E1BE488B8Q33425845-38032D65-F508-4E09-8953-980A71659505Q33722631-2A8C0A2E-BE99-454A-BC83-453DA1928434Q33750986-558EBB56-44C1-44D8-88DF-4BA599C13021Q33754235-4C82A14B-7B91-4A4C-A5DB-CF32D5078361Q33786718-862DDC79-19EF-4816-8081-C2CDCA02DDF1Q33882126-C8BB8AA2-D9CC-41C2-9C15-D5AB6BB0075CQ34290672-C6012AAF-5DE5-42C6-9269-70E44599A15FQ34450365-3E767774-B662-444E-AB52-652E07E8D32AQ34558763-F17F4A7E-9BCE-435D-87EE-F6775674467AQ34561775-0AD4F1E4-8B89-468E-9AB6-C1F85A48AD40Q34657881-4A20B135-2906-41A1-ADCA-BEB42C3B93ADQ35017059-F382932E-E0F8-4E5B-8C10-35A80C71480CQ35038284-EF8E617E-2770-4D03-8853-82477119C9BEQ35041304-0C5BBC49-225D-4F5B-99B2-E7803088B938Q35065285-3A8C4E19-5D87-41DB-B035-C82D73B10C11Q35115833-11B5B9BE-00BA-499E-90F1-8C564B15EC89Q35122727-CD1CD192-DF3E-49FF-A43D-06999328EABD
P2860
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@en
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@nl
type
label
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@en
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@nl
prefLabel
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@en
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@nl
P2093
P1476
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
@en
P2093
Jay S Steingrub
Meng-Shiou Shieh
Michael B Rothberg
Penelope S Pekow
Peter K Lindenauer
P304
P356
10.1097/CCM.0B013E318232DB65
P407
P577
2012-03-01T00:00:00Z